Outcome of the Board Meeting held on 30th August, 2025 with regard to upcoming AGM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech's board, meeting on 30th August 2025, set the 33rd AGM for 29th September 2025 via video conferencing, with e-voting from 26–28 September and 22 September as the cut-off date. The board approved the disinvestment of its material subsidiary Dindigul Farm Product Limited (DFPL), which contributed Rs. 6,282.81 lakhs (47.11%) to consolidated turnover and Rs. 3,521.13 lakhs (35.24%) to consolidated net worth as of 31 March 2025. The board rescinded a prior resolution on authorised share capital increase and replaced it with a fresh proposal to raise authorised capital to Rs. 85 crores (8.5 crore equity shares of Rs. 10 each). Multiple directors were appointed or re-appointed, including three Whole-time Directors and one Independent Director, each for a five-year term. The board also approved material related party transactions of up to Rs. 25 crores each with six subsidiaries including DFPL, HSL Agri Solutions, and IBL Healthcare.
The most material items for shareholders are the proposed sale of DFPL — a subsidiary contributing nearly half of consolidated revenue — and the sharp increase in authorised share capital, which opens the door for a future equity raise or share split. AGM approval will be required for both, so investors should watch the 29 September meeting and the e-voting results closely.